Rubrik: GMP / GLP / GCP
(Treffer aus pharmind, Nr. 02, Seite 216 (2017))
Calixto J | Bärtschi B
Comparison of GDP Between Brazil, WHO and EMA / International Requirements and Scenario Concerning Good Distribution and Transport Practices · Calixto J, Bärtschi B ·
1Sindusfarma, São Paulo, Brazil und
2Bioforce AG/A.Vogel-Produkte, Roggwil, Switzerland
Concerning GDP, the following questions have to be answered: What does happen to the quality of the medicines after their distribution? What does happen when the pharmaceutical products leave the company? Who does control the product quality? What about the temperature standards? What is most appropriate for the supply chain? How have the companies prepared themselves with regard to requirements, the changes of the requirements and the geography in each region?